We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Cedars-Sinai Hospital to Use FitBit to Measure Patient Mobility

By HospiMedica International staff writers
Posted on 03 Feb 2016
Print article
Image: The Fitbit Charge HR activity wristband (Photo courtesy of Fitbit).
Image: The Fitbit Charge HR activity wristband (Photo courtesy of Fitbit).
Cedars-Sinai Medical Center (Los Angeles, CA, USA) is conducting a study to see if using an activity bracelet could help assess if oncologic patients are active enough for chemotherapy.

The short, two-week trial will enroll 30 patients in advanced stages of cancer who are ambulatory, over 18, and have access to an internet-connected smartphone. The trial will mainly be a feasibility study, seeing how effective a Fitbit (San Francisco, CA, USA) activity bracelet, as well as questionnaires, are at monitoring the target population. All 30 patients will be given Fitbit Charge HR device and will be asked to wear it at all times, other than in the bath and other times the tracker would be submerged.

The patients will also fill out questionnaires at two oncologist visits during the trial period, and again at a six month follow-up. Researchers will also review mortality and hospitalization for the subjects, as well as whether they wore the device as directed. They will also examine whether the combination of the Fitbit device and the patient-reported-outcome questionnaires can help physicians screen patients for subjective measures such as fatigue, distress, pain, and trouble sleeping, which patients can tend to under-report.

“What we know is that individuals who are up and about tend to be more able to tolerate chemotherapy and have a greater potential for benefitting from it,” said lead investigator Arvind Shinde, MD, of the departments of supportive care medicine, hematology, and oncology. “People who are spending more time in bed usually get harmed by the treatment we give, even if the cancer is responsive to the treatment.”

“A 30-patient study is not enough to give us all the data we need; the two-week trial is something of a dry run to get the kinks of data collection ironed out. The next step will be to do a larger study across multiple tumor types and follow people longitudinally for a much longer period of time,” added Dr. Shinde. “We can see how they do as they progress through their treatments, follow their ups and downs. We’ll be able to get changes over baseline and create a better algorithm for this assessment.”

The Fitbit Charge HR is an activity wrist band that offers continuous heart rate monitoring for better estimation of daily activity, tracking workouts, and monitoring resting heart rate and sleep quality. The advanced tracking records daily steps and calories by day and sleep by night, switching between modes based on movement and heart rate data. The device is linked by an app to a smartphone, allowing real time monitoring of daily data. The Charge HR is available in a range of colors, including black, plum, blue, teal, and tangerine.

Related Links:

Cedars-Sinai Medical Center
Fitbit


Gold Member
12-Channel ECG
CM1200B
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Brachytherapy Planning System
Oncentra Brachy

Print article

Channels

Critical Care

view channel
Image: Researchers have developed a novel risk score for cardiovascular complications after bone marrow transplant (Photo courtesy of 123RF)

Novel Tool Predicts Cardiovascular Risks after Bone Marrow Transplantation

Every year, thousands of people undergo bone marrow transplants to potentially cure serious diseases like leukemia, lymphoma, and immune deficiency disorders. While these transplants can be lifesaving,... Read more

Surgical Techniques

view channel
Image: The Early Bird Bleed Monitoring System provides visual and audible indicators of the onset and progression of bleeding events (Photo courtesy of Saranas)

Novel Technology Monitors and Lowers Bleeding Complications in Patients Undergoing Heart Procedures

Bleeding complications at the femoral access site can significantly hamper recovery, affecting the success of procedures, patient satisfaction, and overall healthcare costs. It is crucial for surgeons... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Point of Care

view channel
Image: The new eye-safe laser technology can diagnose traumatic brain injury (Photo courtesy of 123RF)

Novel Diagnostic Hand-Held Device Detects Known Biomarkers for Traumatic Brain Injury

The growing need for prompt and efficient diagnosis of traumatic brain injury (TBI), a major cause of mortality globally, has spurred the development of innovative diagnostic technologies.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.